Luye Pharma Acquires Remaining Stake Of Beijing Jialin
October 28, 2014 — 11:35 CST
This Data Is Locked!
This area is available only to Subscribers.
Yantai, Shandong Province-based Chinese drug-maker Luye Pharma Group Ltd., backed by Chinese private equity investors, has agreed to acquire the remaining 42.02% stake of Beijing... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
